Sukhija Remy
SEC CIK 1806949 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Chief Commercial Off | 15.0K | — | $8.22M | 3 | 2022-12-23 | 2023-01-16 |
Most active insiders at MDGL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRIEDMAN PAUL A | Dir | — | $26.66M |
| 2 | Taub Rebecca | Dir | — | $21.68M |
| 3 | Sibold William John | Pres, CEO, Dir | — | $10.48M |
| 4 | BATE KENNETH | Dir | — | $8.03M |
| 5 | Levy Richard S | Dir | — | $7.36M |
| 6 | Dier Mardi | EVP, CFO | — | $3.77M |
| 7 | Huntsman Carole | Chief Commercial Off | — | $1.71M |
| 8 | Soergel David | Chief Medical Off | — | $952.0K |
| 9 | Kelley Shannon T | GC | — | $841.6K |
| 10 | Thakkar Rita | CAO | — | — |
Sukhija Remy made no open-market trades at MDGL in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-18 | 2023-01-16 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sukhija Remy | Chief Commercial Off | A - Grant | $0.00 | +15.0K | 15.0K | New | $0 | |
| DM | 2022-12-28 | 2022-12-23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sukhija Remy | Chief Commercial Off | S - Sale+OE | $274.14 | -30.0K | 9,734 | -76% | -$8.22M |
| D | 2022-12-28 | 2022-12-23 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Sukhija Remy | Chief Commercial Off | M - OptEx | $60.26 | +30.0K | 30.0K | New | +$1.81M |
Purchase Sale Sale after option exercise All abbreviations